<DOC>
	<DOCNO>NCT02270840</DOCNO>
	<brief_summary>Effect biventricular upgrade leave ventricular reverse remodel clinical outcome patient leave ventricular dysfunction intermittent permanent apical/septal right ventricular pacing ( Budapest CRT upgrade study )</brief_summary>
	<brief_title>Budapest Upgrade CRT Study ( Version 009-4.1 )</brief_title>
	<detailed_description>The aim study investigate effect upgrade CRT-D device clinical echocardiographic response 12-month patient leave ventricular dysfunction ( LVEF ≤35 % ) , symptomatic heart failure ( NYHA II , III , IV-a ) , intermittent permanent right ventricular pace paced QRS complex ≥ 150 m compare continued therapy single dual chamber pacemaker ( PM ) ICD . Prospective , post-market , international multicenter randomize control trial .</detailed_description>
	<mesh_term>Cardiomyopathies</mesh_term>
	<criteria>Male female patient age 18 ( expect survival time : 1 year ) Patients ischemic nonischemic cardiomyopathy ; Those implanted single dual chamber ICD implant single dual chamber pacemaker least 6 month inclusion ; Elective generator replacement upgrade pacemakeronly ICD therapy may indicate time enrollment , require ; Right ventricular pace 20100 % least last 90 day enrollment ( optimal AV interval base physician 's discretion avoid unnecessary right ventricular stimulation ) ; Symptomatic heart failure least 3 month inclusion ; NYHA functional class II III , IV ; Left ventricular ejection fraction measure echocardiography ≤ 35 % ; Paced QRS complex ≥ 150 m ; Optimal heart failure medical therapy ; Informed consent obtain . Intrinsic QRS LBBB morphology ( measure VVI 40 bpm set per protocol ) ; CABG PCI past 3 month ; Acute myocardial infarction past 3 month ; Unstable angina ; Planned coronary revascularization ( PCI CABG ) ; Planned cardiac transplantation ; Acute myocarditis ; Infiltrative myocardial disease ; Hypertrophic cardiomyopathy ; Severe primary mitral aortic valve stenosis regurgitation ; Women pregnant plan become pregnant breastfeeding ; Subjects unable unwilling cooperate study protocol ; Tricuspid valve prosthesis ; Any serious disease likely interfere conduct study ; Participation clinical trial ; Patients geographically stable unavailable followup ; Chronic , severe renal dysfunction ( creatinine value &gt; 200 μmol/l ) ; Severe RV dilatation ( RV basal diameter &gt; 50mm ) ; Severe tricuspid insufficiency .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>cardiac resynchronization therapy</keyword>
</DOC>